Filtros de búsqueda

Lista de obras de

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

scientific article published on 15 June 2018

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma.

artículo científico publicado en 2015

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

artículo científico publicado en 2016

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

artículo científico publicado en 2013

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

artículo científico publicado en 2017

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

artículo científico publicado en 2018

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

artículo científico publicado en 2009

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

artículo científico publicado en 2009

A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

artículo científico publicado en 2010

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

scientific article published on 30 July 2019

A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year.

artículo científico publicado en 2010

A statistician's perspective on a long time to publish.

artículo científico publicado en 2016

APOE varepsilon2 and presymptomatic stage Alzheimer disease: how much is not enough?

artículo científico publicado en 2010

Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning

scientific article published on 28 February 2019

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

artículo científico publicado en 2015

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

scientific article published on 01 December 2018

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

artículo científico publicado en 2018

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards ⬇️

artículo científico publicado en 2016

Analysis and interpretation of results based on patient-reported outcomes

artículo científico publicado en 2007

Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical Decisions

artículo científico publicado en 2019

Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype

scientific article published on 18 September 2013

Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers

artículo científico publicado en 2011

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

scientific article published on 01 September 2019

Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial

artículo científico publicado en 2019

Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis

scientific article published on 06 July 2019

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

artículo científico publicado en 2017

Association of hospital participation in a surgical outcomes monitoring program with inpatient complications and mortality.

artículo científico publicado en 2015

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

artículo científico publicado en 2016

Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.

artículo científico publicado en 2015

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

scientific article published on 18 June 2018

Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial

artículo científico publicado en 2021

Brain MR Radiomics to Differentiate Cognitive Disorders

artículo científico publicado en 2019

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

artículo científico publicado en 2011

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

artículo científico publicado en 2011

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

scientific article published on 04 December 2018

Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

scientific article published on 01 May 2019

Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice

artículo científico publicado en 2012

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

artículo científico publicado en 2014

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes

artículo científico publicado en 2011

Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.

artículo científico publicado en 2017

Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial

artículo científico publicado en 2020

Clinical and self breast examination remain important in the era of modern screening.

artículo científico

Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis

artículo científico publicado en 2008

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials

artículo científico publicado en 2019

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

artículo científico publicado en 2018

Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

artículo científico publicado en 2020

Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.

artículo científico publicado en 2015

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma.

artículo científico publicado en 2008

Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.

artículo científico publicado en 2011

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

artículo científico publicado en 2007

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

artículo científico publicado en 2011

Dealing with multiple endpoints

artículo científico publicado en 2006

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition

scientific article published on 25 September 2020

Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study

artículo científico publicado en 2013

Determination of mild, moderate, and severe pain interference in patients with cancer

artículo científico publicado en 2017

Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials.

artículo científico

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

artículo científico publicado en 2014

Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer

scientific article published on 01 January 2020

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

artículo científico publicado en 2014

Distinctive Pulmonary Histopathology With Increased IgG4-positive Plasma Cells in Patients With Autoimmune Pancreatitis

scientific article published on 01 October 2009

Does magnetic resonance imaging accurately predict residual disease in breast cancer?

artículo científico publicado en 2009

Does size matter? Technical considerations of a regenerative tissue matrix for use in reconstructive surgery

artículo científico publicado en 2011

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

artículo científico publicado en 2014

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.

artículo científico publicado en 2013

Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object mass distribution for whole-hand manipulation.

artículo científico publicado en 2012

Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object weight for whole-hand manipulation

artículo científico publicado en 2011

Effects of carpal tunnel syndrome on dexterous manipulation are grip type-dependent

artículo científico publicado en 2013

Electronic Patient-Reported Outcomes as Digital Therapeutics to Improve Cancer Outcomes

scientific article published on 02 June 2020

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

artículo científico publicado en 2015

Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial

artículo científico publicado en 2011

Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.

artículo científico publicado en 2017

Expanding beyond maximum grade: Chemotherapy toxicity over time by age and performance status in advanced non-small cell lung cancer in CALGB 9730 (Alliance A151729)

scientific article published on 20 September 2020

Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform

artículo científico publicado en 2010

Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?

artículo científico publicado en 2008

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

artículo científico publicado en 2017

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

artículo científico publicado en 2017

Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms.

artículo científico publicado en 2017

Fibrillar amyloid correlates of preclinical cognitive decline.

artículo científico publicado en 2013

Fracture risk perception study: patient self-perceptions of bone health often disagree with calculated fracture risk.

artículo científico publicado en 2014

Future directions in QOL research

artículo científico publicado en 2005

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

artículo científico publicado en 2015

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

artículo científico publicado en 2015

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

artículo científico publicado en 2010

Handling missing data

artículo científico publicado en 2005

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).

artículo científico publicado en 2018

IAP antagonists induce anti-tumor immunity in multiple myeloma.

artículo científico publicado en 2016

IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831.

artículo científico publicado en 2017

Identifying patients at risk for obstructive sleep apnea in a primary care practice

artículo científico publicado en 2011

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).

artículo científico publicado en 2013

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development

artículo científico publicado en 2015

Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial

artículo científico publicado en 2013

Impact of Personality on Cognitive Aging: A Prospective Cohort Study.

artículo científico publicado en 2016

Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma

artículo científico publicado en 2015

Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study

scientific article published on 11 August 2019

Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study

scientific article published on 15 September 2020

Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

artículo científico publicado en 2013

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

scientific article published on 15 January 2019

Incorporating clinical significance into a study

scientific article published on 01 November 2005

Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer

artículo científico publicado en 2010

Increased osteoporosis screening rates associated with the provision of a preventive health examination

artículo científico publicado en 2009

Integrating QOL assessments for clinical and research purposes.

artículo científico publicado en 2006

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

artículo científico publicado en 2007

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

artículo científico publicado en 2020

Interpreting and reporting results based on patient-reported outcomes

scientific article published on 01 November 2007

Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects

scientific article published on 06 March 2020

Is pelvic sentinel node biopsy necessary for lower extremity and trunk melanomas?

artículo científico publicado en 2017

Is the use of QOL data really any different than other medical testing?

artículo científico publicado en 2006

Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?

scientific article published on October 2009

Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials.

artículo científico publicado en 2004

Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies ⬇️

artículo científico publicado en 2019

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review

artículo científico publicado en 2020

Laparoscopic radical nephrectomy for very large renal tumors (> or =10 cm): is there a size limit?

artículo científico publicado en 2009

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

artículo científico publicado en 2016

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study

scholarly article by Joseph Mikhael et al published 29 August 2018 in Blood Cancer Journal

Limitations of fibrosis grade as diagnostic criteria for post polycythemia vera and essential thrombocytosis myelofibrosis

artículo científico publicado en 2015

Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit

artículo científico publicado en 2016

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

artículo científico publicado en 2020

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

artículo científico publicado en 2020

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect

artículo científico publicado en 2009

Longitudinal modeling of cognitive aging and the TOMM40 effect

artículo científico publicado en 2012

Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers

artículo científico publicado en 2011

MEDICAL AND NEURO-ONCOLOGY

artículo científico publicado en 2011

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.

artículo científico publicado en 2016

Malignant melanoma in the elderly: different regional disease and poorer prognosis.

artículo científico publicado en 2011

Measuring outcomes in randomized prospective trials in palliative care

artículo científico publicado en 2007

Meeting on the FDA draft guidance on patient-reported outcomes

artículo científico publicado en 2007

Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

artículo científico publicado en 2010

Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials

artículo científico publicado en 2016

Microsatellitosis in Patients with Melanoma

artículo científico publicado en 2018

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Event

artículo científico publicado en 2016

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials ⬇️

article by Andrew Bottomley et al published December 2018 in Clinical Trials

Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma

artículo científico publicado en 2015

Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.

artículo científico publicado en 2017

Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.

artículo científico publicado en 2015

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

artículo científico publicado en 2012

Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls

artículo científico publicado en 2015

N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.

artículo científico publicado en 2013

NIMG-68. ACCURATE PATIENT-SPECIFIC MACHINE LEARNING MODELS OF GLIOBLASTOMA INVASION USING TRANSFER LEARNING

artículo científico publicado en 2017

NIMG-74. RADIOMICS OF TUMOR INVASION 2.0: COMBINING MECHANISTIC TUMOR INVASION MODELS WITH MACHINE LEARNING MODELS TO ACCURATELY PREDICT TUMOR INVASION IN HUMAN GLIOBLASTOMA PATIENTS

scholarly article by Kristin R Swanson et al published 6 November 2017 in Neuro-Oncology

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities.

artículo científico publicado en 2011

Neuropsychological comparison of incident MCI and prevalent MCI

artículo científico publicado en 2018

Neuropsychological decline up to 20 years before incident mild cognitive impairment

scientific article published on 06 January 2020

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer

artículo científico publicado en 2009

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

artículo científico publicado en 2012

Nurse leader mindfulness meditation program for stress management: a randomized controlled trial

artículo científico publicado en 2009

Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.

artículo científico publicado en 2019

Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.

artículo científico publicado en 2017

Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas

artículo científico publicado en 2009

Oral idasanutlin in patients with polycythemia vera

scientific article published on 05 June 2019

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

artículo científico publicado en 2009

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

artículo científico publicado en 2017

Patient Perspectives Regarding Allogeneic Bone Marrow Transplant in Myelofibrosis

artículo científico publicado en 2018

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease

scientific article published on 10 March 2020

Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials

scientific article published on 19 September 2018

Patient-Reported Symptom Monitoring During Chemotherapy-Reply

artículo científico publicado en 2017

Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data

artículo científico publicado en 2016

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

scientific article published on 16 July 2020

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

artículo científico publicado en 2019

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

artículo científico publicado en 2019

Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment.

artículo científico publicado en 2018

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

artículo científico publicado en 2020

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

scientific article published on 22 January 2019

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2016

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5

artículo científico publicado en 2006

Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma

artículo científico publicado en 2015

Population-level evidence of survival benefits of patient-reported outcome symptom monitoring software systems in routine cancer care

artículo científico publicado en 2020

Positive margins after breast-conserving therapy: localization technique or tumor biology?

artículo científico publicado en 2011

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

artículo científico publicado en 2016

Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria

artículo científico publicado en 2011

Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants

artículo científico publicado en 2015

Preoperative predictors of nipple-areola complex involvement for patients undergoing mastectomy for breast cancer

artículo científico publicado en 2011

Pretransplant risk score for new-onset diabetes after kidney transplantation

artículo científico publicado en 2011

Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients.

artículo científico publicado en 2017

Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying.

artículo científico publicado en 2015

Public perceptions of presymptomatic testing for Alzheimer disease

artículo científico publicado en 2014

Quality of life after breast cancer surgery: What have we learned and where should we go next?

artículo científico publicado en 2009

Quality of life and disease understanding: impact of attending a patient-centered cancer symposium

artículo científico publicado en 2015

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?

artículo científico publicado en 2018

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.

artículo científico publicado en 2013

Radiogenomics to characterize regional genetic heterogeneity in glioblastoma

artículo científico publicado en 2016

Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.

artículo científico publicado en 2009

Rates of residual disease with close but negative margins in breast cancer surgery

artículo científico publicado en 2015

Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.

artículo científico publicado en 2012

Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials

artículo científico publicado en 2014

Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocy

artículo científico publicado en 2013

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival

artículo científico publicado en 2012

Regional recurrence in the era of sentinel lymph node biopsy

scientific article published on 28 September 2015

Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus

artículo científico publicado en 2010

Reply to Comment on "Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment"

article

Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma

artículo científico publicado en 2016

Risk factors associated with local and in-transit recurrence of cutaneous melanoma

artículo científico publicado en 2010

Robust estimation of multivariate covariance components.

artículo científico publicado en 2005

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study

artículo científico publicado en 2018

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

artículo científico publicado en 2017

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle

artículo científico publicado en 2016

Scientific Presentation Award: The impact of magnetic resonance imaging on surgical treatment of invasive breast cancer.

artículo científico publicado en 2009

Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes

artículo científico publicado en 2010

Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?

artículo científico publicado en 2015

Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study

artículo científico publicado en 2018

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831

artículo científico publicado en 2013

Sorafenib for Advanced and Refractory Desmoid Tumors

artículo científico publicado en 2018

Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review ⬇️

Stratifying SLN incidence in intermediate thickness melanoma patients.

artículo científico publicado en 2017

Subjective Cognitive Impairment and the Broad Autism Phenotype

scientific article published on 01 October 2018

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

artículo científico publicado en 2015

Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs

artículo científico publicado en 2017

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

artículo científico publicado en 2015

The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes

scientific article published on 01 November 2007

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients

artículo científico publicado en 2011

The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms

artículo científico publicado en 2020

The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?

artículo científico publicado en 2011

The clinical significance of quality of life assessments in oncology: a summary for clinicians

artículo científico publicado en 2006

The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials

artículo científico publicado en 2017

The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes

artículo científico publicado en 2009

The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.

artículo científico publicado en 2011

The impact of concomitant medication use on patient eligibility for phase I cancer clinical trials.

artículo científico publicado en 2012

The impact of obesity on breast cancer: a retrospective review.

artículo científico publicado en 2012

The neuropsychology of normal aging and preclinical Alzheimer's disease

artículo científico publicado en 2013

The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts.

artículo científico publicado en 2016

The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing.

artículo científico publicado en 2015

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.

artículo científico publicado en 2015

The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group

artículo científico publicado en 2016

Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)

scientific article published on 19 September 2020

Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin

artículo científico publicado en 2020

Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience.

artículo científico publicado en 2013

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

artículo científico publicado en 2018

Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center.

artículo científico publicado en 2016

Triple-negative breast cancers: unique clinical presentations and outcomes

artículo científico publicado en 2010

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

artículo científico publicado en 2019

Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement

artículo científico publicado en 2017

Validation of a gastric cancer nomogram using a cancer registry.

artículo científico publicado en 2015

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

artículo científico publicado en 2015

What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda